Interferon gamma release assays in the evaluation of children with possible mycobacterium tuberculosis infection: A view to caution

Pediatric Infectious Disease Journal

Volumn 28, Issue 8, 2009, Pages 676-677

  Powell, Dwight A ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

CHILDHOOD DISEASE; DISEASE COURSE; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NOTE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 68649104284     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181ad5490     Document Type: Note

References (25)

1. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28:669-673.
2. Bergamini BM, Losi M, Vaienti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009;123:e419-e424.
3. Lighter J, Rigaud M, Eduardo R, et al. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics. 2009;123:30-37.
4. Connell TG, Curtis N, Ranganathan SC, et al. Peformance of whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax. 2006;61:616-620.
5. Connell TG, Paxton GA, Buttery JP, et al. A three-way comparison of tuberculin skin testing, QuantiFERON-TB Gold and T.SPOT.TB in children. PloS ONE. 2008;3:e2624.
6. Tsiouris SJ, Austin J, Toro P, et al. Results of a tuberculosis-specific IFN-γ assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis. 2006;10:939-941.
7. Chun J-K, Kim CK, Kim HS, et al. The role of a whole interferon-γ assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children. Diagn Microbiol Infect Dis. 2008;62:389-394.
8. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350:2060-2067.
9. Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the effect of Bacille Calmette-Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804-809.
10. Sleiman R, Al-Tannir M, Dakdouki G, et al. Interpretation of the tuberculin skin test in Bacille Calmette-Guérin vaccinated and nonvaccinated school children. Pediatr Infect Dis J. 2007;26:134-138.
11. Nicol M, Davies MA, Wood K, et al. Comparison of T-SPOT. TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics. 2009;123:38-43.
12. Brodie D, Lederer DJ, Gallardo JS, et al. Use of an interferon-γ release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest. 2008;133:869-874.
13. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a t-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149:777-786.
14. Lewinsohn DA, Zalwango S, Stein CM, et al. Whole Blood interferon-gamma responses to Mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PloS ONE. 2008;3: e3407.
15. Hill PC, Brookes RH, Fox A, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PloS Med. 2007;4:e192.
16. Leyten EM, Arend SM, Prins C, et al. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol. 2007;14:880-885.
17. Cehovin A, Cliff JM, Hill PC, et al. Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol. 2007;14:796-798.
18. Ruhwald M, Petersen J, Kofoed K, et al. Improving t-cell assays for the diagnosis of latent Tb infection: potential of a diagnostic test based on IP-10. PloS ONE. 2008;3:e2858.
19. Petrucci R, Abu Amer N, Gurgel RQ, et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J. 2008;27:1073-1077.
20. Nicol MP, Pienaar D, Wood K, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis. 2005;40:1301-1308.
21. Detjen AK, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007;45:322-328.
22. Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004;364:2196-2203.
23. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007;54: 267-276.
24. Herrmann JL, Belloy M, Porcher R, et al. Temporal dynamics of interferon-γ responses in children evaluated for tuberculosis. PloS ONE. 2009;4: e4130.
25. Powell DA, Hunt WG. Tuberculosis in children: an update. Adv Pediatr. 2006;53:279-322.